Lars M. Koenig

1.0k total citations
12 papers, 619 citations indexed

About

Lars M. Koenig is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Lars M. Koenig has authored 12 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Immunology and 5 papers in Epidemiology. Recurrent topics in Lars M. Koenig's work include interferon and immune responses (4 papers), Gut microbiota and health (3 papers) and Immune cells in cancer (2 papers). Lars M. Koenig is often cited by papers focused on interferon and immune responses (4 papers), Gut microbiota and health (3 papers) and Immune cells in cancer (2 papers). Lars M. Koenig collaborates with scholars based in Germany, United States and Austria. Lars M. Koenig's co-authors include Ece Mutlu, Ali Keshavarzian, John Losurdo, Garth Swanson, Yan Sun, Phillip A. Engen, Alan Landay, Christopher B. Forsyth, Charles M. Burns and Basile Siewe and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Frontiers in Immunology.

In The Last Decade

Lars M. Koenig

12 papers receiving 616 citations

Peers

Lars M. Koenig
John Losurdo United States
Justin Chan United States
Shulin Qin United States
Emily J. Ciccone United States
Lars M. Koenig
Citations per year, relative to Lars M. Koenig Lars M. Koenig (= 1×) peers Gema Méndez‐Lagares

Countries citing papers authored by Lars M. Koenig

Since Specialization
Citations

This map shows the geographic impact of Lars M. Koenig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars M. Koenig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars M. Koenig more than expected).

Fields of papers citing papers by Lars M. Koenig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars M. Koenig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars M. Koenig. The network helps show where Lars M. Koenig may publish in the future.

Co-authorship network of co-authors of Lars M. Koenig

This figure shows the co-authorship network connecting the top 25 collaborators of Lars M. Koenig. A scholar is included among the top collaborators of Lars M. Koenig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars M. Koenig. Lars M. Koenig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Mann, Carina C. de Oliveira, Stephan A. Müller, Michael Kluge, et al.. (2021). OAS1/RNase L executes RIG-I ligand–dependent tumor cell apoptosis. Science Immunology. 6(61). 29 indexed citations
2.
Linder, Andreas, Nicolas Linder, Christoph Bartenhagen, et al.. (2021). Defective Interfering Genomes and the Full-Length Viral Genome Trigger RIG-I After Infection With Vesicular Stomatitis Virus in a Replication Dependent Manner. Frontiers in Immunology. 12. 595390–595390. 20 indexed citations
3.
Segura‐Bayona, Sandra, et al.. (2020). Tousled-Like Kinases Suppress Innate Immune Signaling Triggered by Alternative Lengthening of Telomeres. Cell Reports. 32(5). 107983–107983. 21 indexed citations
4.
Magg, Thomas, Philipp Metzger, Meino Rohlfs, et al.. (2020). A Novel Complete Autosomal-Recessive STAT1 LOF Variant Causes Immunodeficiency with Hemophagocytic Lymphohistiocytosis–Like Hyperinflammation. The Journal of Allergy and Clinical Immunology In Practice. 8(9). 3102–3111. 20 indexed citations
5.
Meßner, Martina, Sabine Schmitt, Thomas Fröhlich, et al.. (2020). Metabolic implication of tigecycline as an efficacious second‐line treatment for sorafenib‐resistant hepatocellular carcinoma. The FASEB Journal. 34(9). 11860–11882. 10 indexed citations
6.
Gupta, Aditya, et al.. (2019). Fungal Diversity and Onychomycosis. Journal of the American Podiatric Medical Association. 109(1). 57–63. 17 indexed citations
7.
Koenig, Lars M., Binje Vick, Julia Ahlfeld, et al.. (2019). RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade. Leukemia. 34(4). 1017–1026. 33 indexed citations
8.
Metzger, Philipp, Sabrina V. Kirchleitner, Michael Kluge, et al.. (2019). Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer. Journal for ImmunoTherapy of Cancer. 7(1). 288–288. 25 indexed citations
9.
Metzger, Philipp, Sabrina V. Kirchleitner, Lars M. Koenig, et al.. (2018). Dying cells expose a nuclear antigen cross-reacting with anti-PD-1 monoclonal antibodies. Scientific Reports. 8(1). 8810–8810. 9 indexed citations
10.
Keshavarzian, Ali, Garth Swanson, Mark T. DeMeo, et al.. (2016). The Effects of Bowel Preparation on Microbiota-Related Metrics Differ in Health and in Inflammatory Bowel Disease and for the Mucosal and Luminal Microbiota Compartments. Clinical and Translational Gastroenterology. 7(2). e143–e143. 81 indexed citations
11.
Patel, Aloka L., Ece Mutlu, Yan Sun, et al.. (2015). Longitudinal Survey of Microbiota in Hospitalized Preterm Very‐Low‐Birth‐Weight Infants. Journal of Pediatric Gastroenterology and Nutrition. 62(2). 292–303. 54 indexed citations
12.
Mutlu, Ece, Ali Keshavarzian, John Losurdo, et al.. (2014). A Compositional Look at the Human Gastrointestinal Microbiome and Immune Activation Parameters in HIV Infected Subjects. PLoS Pathogens. 10(2). e1003829–e1003829. 300 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026